Lobbying Spend
—
Filings
28
Firms Hired
2
Active Period
2021–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · third_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.
Client expense: — · Firm income: $40,000
Matched citations: HR.1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · second_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.
Client expense: — · Firm income: $40,000
Matched citations: HR.1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · first_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.
Client expense: — · Firm income: $40,000
Matched citations: HR.1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · fourth_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
Client expense: — · Firm income: $40,000
Matched citations: HR.1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
Client expense: — · Firm income: $40,000
Matched citations: HR.1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
Client expense: — · Firm income: $40,000
Matched citations: HR.1
Lower Costs, More Transparency Act
2024 · fourth_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act and H.R.5378 - Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia.
Client expense: — · Firm income: $40,000
Matched citations: H.R.5378
Modernizing and Ensuring PBM Accountability Act
2024 · fourth_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2973
Modernizing and Ensuring PBM Accountability Act
2024 · fourth_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act and H.R.5378 - Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia.
Client expense: — · Firm income: $40,000
Matched citations: S.2973
Lower Costs, More Transparency Act
2024 · third_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act and H.R.5378 - Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia.
Client expense: — · Firm income: $40,000
Matched citations: H.R.5378
Modernizing and Ensuring PBM Accountability Act
2024 · third_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act and H.R.5378 - Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia.
Client expense: — · Firm income: $40,000
Matched citations: S.2973
Modernizing and Ensuring PBM Accountability Act
2024 · third_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2973
Lower Costs, More Transparency Act
2024 · second_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act and H.R.5378 - Lower Costs, More Transparency Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.5378
Modernizing and Ensuring PBM Accountability Act
2024 · second_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2973
Modernizing and Ensuring PBM Accountability Act
2024 · second_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act and H.R.5378 - Lower Costs, More Transparency Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2973
Lower Costs, More Transparency Act
2024 · first_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act and H.R.5378 - Lower Costs, More Transparency Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.5378
Modernizing and Ensuring PBM Accountability Act
2024 · first_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act and H.R.5378 - Lower Costs, More Transparency Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2973
Modernizing and Ensuring PBM Accountability Act
2024 · first_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2973
Modernizing and Ensuring PBM Accountability Act
2023 · fourth_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2973
Modernizing and Ensuring PBM Accountability Act
2023 · fourth_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2973
Modernizing and Ensuring PBM Accountability Act
2023 · third_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding Step Therapy Reform, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2973
Modernizing and Ensuring PBM Accountability Act
2023 · third_quarter · Firm: CAPITOL COUNSEL LLC
Issues regarding Step Therapy Reform, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2973
Source: Senate LDA